Account
Dentsu Webchutney wins digital & social media mandate for ACKO
MUMBAI: Dentsu Webchutney, the digital creative agency from the house of dentsu India, has won the social media mandate for digital insurance policy provider, ACKO General Insurance. The account was won following a multi-agency pitch.
In four years, the insurance brand, with its entire operations offered through the digital platform ACKO has set new benchmarks for customer experience in an otherwise slow-moving category. Dentsu Webchutney comes in with a specific goal to grow ACKO’s place in the market, with an always-on social excellence approach.
Dentsu Webchutney vice president GD Prasad said, “In a short time, ACKO has established itself as a disruptive brand that every player in the category will soon follow. To partner with them, is to take another step into the deep end of the impact of digital technologies. We have the enviable chance to build a brand whose actions are aligned with its values. We will continue to push the bar for them in what has turned out to be a year of fantastic partnerships with disruptive new brands for Dentsu Webchutney.“
ACKO General Insurance executive VP—marketing, Ashish Mishra added, “We are absolutely thrilled to be joining forces with Dentsu Webchutney. Partnering with them to lead our charter on digital marks the beginning of a journey that is filled with intent and backed by action. We are certain that Dentsu Webchutney, with their nuanced understanding of the digital landscape, will fuel our vision to be the country’s most loved general insurance brand.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
